Showing results (441-450 of 601) with videos related to

Sort By:
Pageof 61
Blood|June 23, 2010
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trialJong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, et al.
Journal of the American College of Cardiology|April 24, 2010
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) studyDavid J Whellan, Kevin T Ousdigian, Sana M Al-Khatib, et al.
Journal of Neuro-Oncology|July 18, 2008
Retrospective review of adjuvant chemotherapy for esthesioneuroblastomaAlyx B Porter, Dirk M Bernold, Caterina Giannini, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 10, 2015
Lumbar plexus block surface landmarks as assessed by computed axial tomography in adult patients with scoliosis: a case seriesChristopher B Robards, Kevin Riutort, Colleen S Thomas, et al.
European Journal of Haematology|February 19, 2015
Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatmentJohn B Porter, Mohsen El-Alfy, Vip Viprakasit, et al.
Haematologica|April 16, 2013
Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC studyJong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, et al.
The Journal of Bone and Joint Surgery. American Volume|July 10, 2025
The Timing of Direct Oral Anticoagulant Usage Did Not Impact Outcomes Following Hip Arthroplasty for Femoral Neck FracturesXiao T Chen, Bryan D Springer, Shalmali Borkar, et al.
American Heart Journal|September 1, 1993
Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarctionJ L Vacek, T L Rosamond, P H Kramer, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2004
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram doseGerald J Fetterly, Christine M Ong, Sujata M Bhavnani, et al.
American Journal of Hematology|July 27, 2023
SLN124, a GalNAc conjugated 19-mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteersJohn B Porter, Alison Scrimgeour, Alberto Martinez, et al.
Pageof 61